Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Retirement Plan Analyst/Administrator

Compensation Strategies Group, Ltd.
(Remote / Beaumont TX)

Compensation Strategies Group, Ltd. logo

Education Consultant

Pentegra
(Remote / Putnam Valley NY)

Pentegra logo

Retirement Plan Administrator

Nicholas Pension Consultants
(Remote / Corona CA / Rancho Cordova CA)

Nicholas Pension Consultants logo

Quality Assurance Manager

Nova 401(k) Associates
(Remote)

Nova 401(k) Associates logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile App image LinkedIn icon
Twitter icon
Facebook icon

<< Previous news item   |   Next news item >>



Thinking About Drug Price Controls
Steven Pearlstein in The Washington Post; subscription may be requiredLink to more items from this source
May 27, 2004
Excerpt: Washington Post columnist Steven Pearlstein was online to talk about whether the government should study the cost-effectiveness of new medicines and then use that information to determine how much Medicare should pay drugmakers. In his column today, Pearlstein concludes: 'The question isn't whether we'll ration and manage, but who will do it and how. And sooner we start talking about it openly, the better things will turn out.'

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).
© 2022 BenefitsLink.com, Inc.